Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

Nobel Biocare N1 TiUltra TCC RP 4.0x7mm: medical device reports filed with FDA

734 reports name it, 2022–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

734
device reports naming the brand
0% of all MAUDE reports · about 167 a year
154
reports, 12 months to August 2026
138 in the 12 months before
1.4%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

734 medical device reports received by FDA name the brand "Nobel Biocare N1 TiUltra TCC RP 4.0x7mm" (endosseous dental implant); the manufacturer given most often on reports is Nobel Biocare; received from February 2022 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.

154 reports arrived in the 12 months to August 2026, up 12% from 138 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (98.6%) and malfunction (1.4%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (64.9%), loss of osseointegration (17.2%) and osseointegration problem (8.2%). The patient problems coded most often are failure of implant, pain and inflammation. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

02244Sep 2021: 0Oct 2021: 0Nov 2021: 0Dec 2021: 02022Jan 2022: 0Feb 2022: 6Mar 2022: 18Apr 2022: 16May 2022: 14Jun 2022: 28Jul 2022: 14Aug 2022: 14Sep 2022: 16Oct 2022: 12Nov 2022: 6Dec 2022: 182023Jan 2023: 16Feb 2023: 10Mar 2023: 24Apr 2023: 8May 2023: 11Jun 2023: 13Jul 2023: 14Aug 2023: 12Sep 2023: 12Oct 2023: 8Nov 2023: 22Dec 2023: 302024Jan 2024: 18Feb 2024: 16Mar 2024: 8Apr 2024: 14May 2024: 10Jun 2024: 12Jul 2024: 16Aug 2024: 6Sep 2024: 20Oct 2024: 10Nov 2024: 22Dec 2024: 62025Jan 2025: 4Feb 2025: 8Mar 2025: 8Apr 2025: 6May 2025: 0Jun 2025: 0Jul 2025: 44Aug 2025: 10Sep 2025: 20Oct 2025: 10Nov 2025: 22Dec 2025: 82026Jan 2026: 8Feb 2026: 8Mar 2026: 12Apr 2026: 10May 2026: 10Jun 2026: 18Jul 2026: 16Aug 2026: 12

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

0901802022: 16220222023: 18020232024: 15820242025: 14020252026: 942026

Event type and report source

Event type, as classified on the report

Death0%0
Injury98.6%724
Malfunction1.4%10
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%367
Voluntary report0%0
User facility report0%0
Distributor report50%367
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate47664.9%62.8%
Loss of osseointegration12617.2%22.4%
Osseointegration problem608.2%7.7%
Migrationthe device moved from where it was placed121.6%0.1%
Material deformation101.4%0.1%
Premature separation101.4%0.1%
Patient device interaction problem81.1%0.3%
Malposition of device40.5%0.1%
Separation failure40.5%0.1%
Device markings/labelling problema problem with the device markings or label20.3%0%
Difficult to insertthe device was hard to insert20.3%0.4%
Difficult to removethe device was hard to remove20.3%0%
Insufficient device problem information20.3%0.2%
Packaging problem20.3%0%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant51470%
Painpain, site not specified405.4%
Inflammationinflammation121.6%
Abscessa collection of pus81.1%
Appropriate clinical signs, symptoms and conditions term/code not available81.1%
Numbnessnumbness81.1%
Implant pain60.8%
Bone fracture(s)20.3%
Hypersensitivity/allergic reaction20.3%
Sinus perforation20.3%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobel Biocare N1 TiUltra TCC RP 4.0x7mmProduct code DZEAll MAUDE reports
Reports7343,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury98.6%99.2%36.2%
Classified as malfunction1.4%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about Nobel Biocare N1 TiUltra TCC RP 4.0x7mm reports

How many FDA reports name Nobel Biocare N1 TiUltra TCC RP 4.0x7mm?

734 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 154 in the latest 12 months.

What kinds of events are reported?

injury (98.6%) and malfunction (1.4%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (64.9%), loss of osseointegration (17.2%), osseointegration problem (8.2%), migration (1.6%) and material deformation (1.4%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that Nobel Biocare N1 TiUltra TCC RP 4.0x7mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.